1. Home
  2. ADAP vs TUSK Comparison

ADAP vs TUSK Comparison

Compare ADAP & TUSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • TUSK
  • Stock Information
  • Founded
  • ADAP 2008
  • TUSK 2014
  • Country
  • ADAP United Kingdom
  • TUSK United States
  • Employees
  • ADAP N/A
  • TUSK N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • TUSK Oilfield Services/Equipment
  • Sector
  • ADAP Health Care
  • TUSK Energy
  • Exchange
  • ADAP Nasdaq
  • TUSK Nasdaq
  • Market Cap
  • ADAP 212.3M
  • TUSK 211.8M
  • IPO Year
  • ADAP 2015
  • TUSK 2016
  • Fundamental
  • Price
  • ADAP $0.59
  • TUSK $3.18
  • Analyst Decision
  • ADAP Strong Buy
  • TUSK
  • Analyst Count
  • ADAP 4
  • TUSK 0
  • Target Price
  • ADAP $3.16
  • TUSK N/A
  • AVG Volume (30 Days)
  • ADAP 2.0M
  • TUSK 102.9K
  • Earning Date
  • ADAP 11-13-2024
  • TUSK 11-01-2024
  • Dividend Yield
  • ADAP N/A
  • TUSK N/A
  • EPS Growth
  • ADAP N/A
  • TUSK N/A
  • EPS
  • ADAP N/A
  • TUSK N/A
  • Revenue
  • ADAP $175,041,000.00
  • TUSK $187,514,000.00
  • Revenue This Year
  • ADAP $180.15
  • TUSK N/A
  • Revenue Next Year
  • ADAP N/A
  • TUSK $2.48
  • P/E Ratio
  • ADAP N/A
  • TUSK N/A
  • Revenue Growth
  • ADAP 146.27
  • TUSK N/A
  • 52 Week Low
  • ADAP $0.42
  • TUSK $2.50
  • 52 Week High
  • ADAP $2.05
  • TUSK $4.95
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 26.22
  • TUSK 26.29
  • Support Level
  • ADAP $0.75
  • TUSK $3.40
  • Resistance Level
  • ADAP $0.83
  • TUSK $3.74
  • Average True Range (ATR)
  • ADAP 0.07
  • TUSK 0.22
  • MACD
  • ADAP -0.01
  • TUSK -0.08
  • Stochastic Oscillator
  • ADAP 2.36
  • TUSK 2.27

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated, growth oriented energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. Its suite of services includes well-completion services, infrastructure services, natural sand proppant services, drilling services, and other services. The majority of revenues are earned from the well-completion services and geographically from the United States followed by Canada and other countries.

Share on Social Networks: